UNODC is cosponsor of the Joint United Nations Programme on HIV/AIDS - UNAIDS
Project H13 Sensitisation Workshop on Oral Substitution Buprenorphine, 27-29 November 2006
Project H13 Phase I
The Joint Secretary, Ministry of Social Justice and Empowerment is the National Focal Point (NFP) for the project. The overall programme is being mentored by the National Institute of Social Defence (NISD) and the 8 Regional Resource and Training Centres (RRTCs). The All India Institute of Medical Sciences (AIIMS) has been designated as the Regional Learning Centre (RLC) for Oral Substitution Buprenorphine (OSB) by the NFP.
During Phase I of Project H13, Oral Substitution Buprenorphine (OSB) was carried out at 5 Participating centers. The All India Institute of Medical Sciences (AIIMS) was designated by the Ministry of Social Justice and Empowerment as the Regional Learning Center. The centres are:
AIIMS (New Delhi)
SHARAN (New Delhi)
Calcutta Samaritans (Kolkata)
SASO (Imphal)
Presbyterian Hospital (Aizawl),
Findings of Phase I (3 Month Follow-up)
The key findings of the 3-month follow up were:
80% retention rate of clients on Oral Substitution Buprenorphine
The current mean dosage was 5.8 mg
Drug use reduced significantly: from 27.8 days per month at baseline to 5.3 days per month at follow-up.
Injecting drug use reduced significantly: 52.8% respondents reported injecting at baseline and 28.5% at follow-up.
Among those injecting, high risk injecting behaviour reduced
Who Quality of Life Index and Addiction Severity Index Scores showed improvement for clients on Oral Substitution Buprenorphine.
Extension of Phase I
During the extended Phase I of the project, OSB is being scaled up from 5 sites to 15 sites. Of these 15 sites, 8 will carry out OSB as part of a comprehensive package of services and 7 will carry out 'stand alone' OSB interventions.
Comprehensive Package: Rapid Situation and Response Assessment (RSRA), Peer Led Intervention (PLI), Safer Practices (SP), Low Cost Community Based Care and Support (LCCS) and Oral Substitution Buprenorphine (OSB)
